Accendra Health CEO Ed Pesicka to retire by end of 2026; board starts successor search

ACCENDRA HEALTH INC/VA/

CEO Edward A. Pesicka to retire by end of 2026; will also step down from board.
Board has begun successor search; previously identified potential candidates.
Pesicka may serve in advisory capacity post-retirement to ensure smooth transition.
Retirement not due to any disagreement with company operations or policies.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Edward A. Pesicka

President, Chief Executive Officer & Director

ACH · ACCENDRA HEALTH INC/VA/

Filed: August 10, 2026, 6:36 AM ET

On August 10, 2026, Accendra Health, Inc. (the “Company”) announced that Edward A. Pesicka, President, Chief Executive Officer & Director of the Company, notified the board of directors (the “Board”) of the Company of his intention to retire and step down from the Board by the end of 2026, or such earlier time as a successor is appointed.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward A. Pesicka departed as President, Chief Executive Officer & Director at ACCENDRA HEALTH INC/VA/.

Action: retire
Role: President, Chief Executive Officer & Director

Exact text from the filing

On August 10, 2026, Accendra Health, Inc. (the “Company”) announced that Edward A. Pesicka, President, Chief Executive Officer & Director of the Company, notified the board of directors (the “Board”) of the Company of his intention to retire and step down from the Board by the end of 2026, or such earlier time as a successor is appointed.

View on SEC.gov

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR

accession 0001104659-26-092973

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.